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The human bronchial epithelium is composed of multiple, discrete cell 
types that cooperate to perform mucociliary clearance. While previous studies 
have shown that cigarette smoke can alter bronchial epithelial gene expression, 
the underlying effects of this exposure on specific cell types are not well 
understood. In this thesis, single-cell RNA sequencing was used to profile 
bronchial epithelial cells from six current smokers and six never smokers. 
Thirteen cell clusters were identified that were defined by expression of unique 
combinations of nineteen distinct gene sets. This clustering revealed that smoke 
exposure induced expression of a toxin metabolism program that specifically 
associated with ciliated cells. Extensive airway remodeling was also observed, in 
which smoking was associated with loss of club cells as well as goblet cell 
expansion and hyperplasia. Additionally, a previously uncharacterized 
CEACAM5+ KRT8+ epithelial subpopulation was identified in the airways of 
smokers. While it has been shown that most smoking-associated gene 
expression alterations can be reversed upon smoking cessation, a subset of 
these alterations persists in former smokers. The basal layer of the bronchial 
	
	 v 
epithelium is comprised of a multipotent progenitor subpopulation. When 
abnormalities persist in the bronchial epithelium despite normal tissue turnover, 
the source of these abnormalities may be traced to this progenitor population and 
its program of differentiation. Therefore, basal cells were procured from three 
current smokers and three never smokers, differentiated in vitro, and profiled by 
RNA sequencing at eight time points spanning the differentiation procedure. 
Twenty-seven unique sets of co-expressed genes associated with differentiation 
were identified and functionally characterized, a subset of which were abnormally 
expressed in smoker cells. Robust expression of genes involved with the 
unfolded protein response was specifically detected in smoker basal cells. 
Additionally, a smoking-associated delay in the onset of expression of genes 
involved with ciliogenesis was observed. These data therefore indicate that 
smoking has long-term consequences on the differentiated state of the airway 
epithelium. Collectively, the observations outlined in this thesis demonstrate that 
smoking drives a complex landscape of alterations that affects the function and 
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CHAPTER I - INTRODUCTION 
Bronchial epithelial cell biology and smoking 
The human bronchus is lined with a pseudostratified epithelium that acts 
as a physical barrier from exposure to harmful environmental insults such as 
inhaled toxins, allergens, and pathogens1-2.  The primary function of the bronchial 
epithelium is mucociliary clearance, which is the process that mediates the 
capture and removal of inhaled substances1-2. Particulate matter is entrapped in 
a mucosal lining produced by goblet epithelial cells and propelled out of the 
airways by mechanical beating of ciliated epithelial cells1-2. Basal epithelial cells 
are multipotent progenitors responsible for normal tissue homeostasis3-5 and club 
epithelial cells are facultative progenitors capable of ciliated cell regeneration6. 
Studies have shown that smoke exposure alters the function or 
abundance of certain bronchial epithelial cell types. For example, it has been 
reported that ciliary length is decreased in smoker ciliated cells, which might 
reduce their capacity for mucociliary clearance7-8. Increased goblet cell 
abundance has been observed in the airways of smokers9-11 and smoke 
exposure has been shown to enhance mucous production12-14. Additional 
smoking-associated airway epithelial alterations have been identified, such as 
increased epithelial permeability, disrupted cell junctions, and mitochondrial 






Smoking-induced genetic and epigenetic alterations 
Tobacco smoke contains dozens of known carcinogens, which cause 
somatic mutations in bronchial epithelial cells19. In the bronchial epithelium of 
healthy current smokers, allelic loss has been observed in chromosomal regions 
commonly deleted in lung cancer20. Additionally, loss of heterozygosity (LOH) 
mutations have been detected in healthy current smoker bronchial tissue at 
established tumor suppressor loci (e.g. p16, FHIT, p53)21.  These findings 
suggest that smoking-associated mutations specifically localize to genetic 
regions altered during cancer progression. Recently, DNA sequencing was 
performed to profile the genomic content of 17 cancer types obtained from both 
never and current smokers22. It was found that cancer cells obtained from the 
lung and larynx of smokers specifically exhibited a mutational signature 
characterized by frequent cytosine to adenine residue transversion22. Therefore, 
it was hypothesized that carcinogens derived from cigarette smoke consistently 
alter DNA via a specific mutagenic mechanism. Profiling of CpG methylation 
(repetitive stretches of noncoding DNA where cytosines are followed by 
guanines) in the same samples revealed that hyper- and hypomethylation was 
specifically observed in adenocarcinomas from smokers22. In all other cancers, 
including those of the lung and larynx, smoking had very little effect on CpG 
methylation patterns22, although other studies have shown that CpG methylation 





Smoking and lung disease 
Smoking is the leading risk factor for both chronic obstructive pulmonary 
disease (COPD) and lung cancer, which are the 3rd and 5th global leading causes 
of death24. COPD is characterized by a diminished capacity to exhale, resulting in 
airflow obstruction, and is diagnosed with one of three primary subphenotypes: 
(1) small airways obstruction, (2) emphysema and (3) chronic bronchitis25. 
Smoking is the strongest determinant of COPD-associated lung function decline 
and the rate of decline can be dramatically diminished with smoking cessation26. 
Smoking-associated molecular alterations contributing to COPD onset and 
progression, however, are largely unclear. It has been observed that smoking 
promotes an inflammatory state characterized by airway infiltration of 
macrophages and neutrophils27, which is also observed in the airways of COPD 
patients, in addition to lymphocytes28. COPD-associated inflammation is 
enhanced with disease progression28, but explicit mechanistic connections 
amongst smoking, inflammation, and COPD have not been characterized. Onset 
of lung cancer, by contrast, is typically attributed to somatic mutations that arise 
as a consequence of direct exposure to smoke-derived carcinogens. For 
example, activating KRAS mutations are commonly observed in lung 
adenocarcinomas and have been characterized as “driver mutations” capable of 
tumor initiation. A recent study reported that KRAS mutations were detected in 
40% of adenocarcinomas in patients with extensive smoking histories (>15 pack 




suggests that smoking increases the likelihood of KRAS mutagenesis, but the 
mechanism by which the KRAS gene is specifically targeted is unclear. 
Furthermore, driver mutations for the majority of lung adenocarcinomas, 
regardless of smoking history, have not been characterized. The occurrence of 
lung cancer in never smokers also suggests that there are additional non-
smoking-associated, and potentially non-genetic, mechanisms that contribute to 
tumorigenesis. 
 
Airway field of injury 
We have previously shown that bronchial epithelial gene expression is 
altered by cigarette smoke exposure, thereby creating a “field of injury” 
throughout the respiratory tract30. We have also shown that a subset of these 
gene expression alterations is irreversible post-smoking cessation31. Additionally, 
this “field of injury” concept has been extended to lung cancer and COPD. We 
have reported that histologically normal tissue in the bronchial airways of lung 
cancer and COPD patients exhibits distinct disease-associated gene expression 
signatures32-33. Notably, these findings have led to the development of a 
bronchial gene expression diagnostic test for lung cancer (e.g. Percepta®)34. 
 
Significance and research goals 
Transcriptomic studies of human bronchial clinical specimens have 




smoking and lung disease. However, given the complexity of bronchial tissue, the 
biological relevance of specific gene expression alterations cannot be fully 
appreciated without understanding cell type-specificity or functional context. 
Given that advanced stage lung cancer and COPD are largely untreatable and 
associated with high morbidity, it is crucial to detect the onset of these diseases 
at an early stage. Furthermore, in order to develop effective strategies for 
disease prevention and treatment, we must understand how these diseases 
arise. While it is generally accepted that smoking causes lung cancer and COPD, 
we know very little about how this exposure physically alters the bronchus and 
initiates disease processes. Therefore, unbiased screening of biological activity 
by transcriptomic analyses of stages of epithelial differentiation and individual 
subpopulations will allow us to better characterize the molecular impact of 
smoking on the bronchial epithelium and begin to understand the foundation 
upon which diseases, like lung cancer and COPD, are built. 
Therefore, the goal of this thesis research was to characterize the 
functional consequences of smoking by (1) investigating alterations to specific 
cell types and shifts in tissue composition and (2) analyzing its long-term effects 





CHAPTER II - CHARACTERIZING THE EFFECTS OF SMOKE EXPOSURE ON 
THE HUMAN BRONCHIAL EPITHELIUM BY SINGLE-CELL RNA-SEQ 
Introduction 
Inhalation of tobacco smoke exposes the bronchial epithelium to toxins, 
carcinogens, and free radicals35-38, but injuries and abnormalities associated with 
this exposure are complex and have not been fully characterized. Previous 
studies have noted smoking-induced epithelial alterations, such as increased 
goblet cell abundance9-11 and reduced ciliary length7-8, but the specific molecular 
drivers of these phenotypes are unclear. Transcriptomic studies have broadly 
shown that the bronchial epithelium of smokers exhibits robust gene expression 
alterations30-31. Genes up-regulated by smoking were involved with processes 
like xenobiotic metabolism and the oxidative stress response30-31. However, as 
the aforementioned studies profiled bronchial tissue in bulk, RNA was pooled 
together from all cells in those tissue samples, potentially masking cell type-
specific contributions to the smoking-associated gene expression alterations. 
To overcome the limitations of bulk tissue analyses, we used single-cell 
RNA sequencing (scRNA-Seq) to profile the transcriptomes of individual 
bronchial cells from healthy never and current smokers. We identified bronchial 
subpopulations using an unsupervised machine learning algorithm called Latent 
Dirichlet Allocation (LDA) then immunostained bronchial tissue from independent 
cohorts of never and current smokers to validate robust smoking-associated 




to ciliated cells, a shift in the presence of club and goblet cells, and the 
emergence of a previously uncharacterized epithelial subpopulation. 
Methods 
Bronchial tissue collection for single cell RNA sequencing 
At Boston University Medical Center (BUMC), healthy, volunteer never 
smokers (n=6) and current smokers (n=6) underwent a bronchoscopy to obtain 
brushings from the right main-stem bronchus as described previously 
described20, 21. Eligible volunteers included subjects who were 1) between the 
ages of 19 and 55; 2) did not use inhaled or intranasal medications; 3) did not 
have history of COPD, asthma, pulmonary fibrosis, or sarcoid, head & neck, or 
lung cancer; 4) did not use marijuana; 5) did not have a respiratory infection 
within the past 6 weeks; and 6) did not use other tobacco products (i.e. pipe, 
cigar, chewing). Spirometry was performed to assess lung function (e.g. 
FEV1/FVC). Exhaled carbon monoxide (Smokerlyzer Carbon Monoxide Monitor, 
ModelEC-50; Bedfont Scientific Ltd) and urine cotinine (NicAlert; Confirm 
BioSciences) levels were measured to confirm smoking status. The Institutional 
Review Board approved the study and all subjects provided written informed 
consent. 
Single Cell isolation by FACS 
Bronchial brushings were treated with 0.25% Trypsin/EDTA for 20 minutes 




height vs. forward scatter area (FSC-H vs. FSC-A) was applied to sort only 
singlet events (Figure 2.2A). Dead cells (LIVE/DEAD Fixable Aqua Dead Cell 
Stain, ThermoFisher; L34957) and red blood cells expressing GYPA/B (Figure 
2.2B) on their surface (APC anti-CD235ab; BioLegend; 306607) were stained 
and excluded. ALCAM+ epithelial cells (PE anti-CD166; BioLegend; 343903) and 
CD45+ white blood cells (APC-Cy7 anti-CD45; BD; 561863) were stained (Figure 
2.2C) and sorted into 96-well PCR plates containing lysis buffer (0.2% Triton-X 
100, 2.5% RNaseOUT (ThermoFisher; 10777019)) compatible with downstream 
RNA library preparation. In each 96-well PCR plate for each subject, we sorted 
84 ALCAM+ cells, 11 CD45+ cells, and maintained one empty well as a negative 
control. The plates were frozen on dry ice, and stored at -80 °C until preparation 
for sequencing. Assessment of ALCAM and EPCAM (PerCP/Cy5.5 anti-EPCAM; 
BioLegend; 342213) co-staining was also performed using cells obtained by 
bronchial brushing (Figure 2.2D). 
Single-cell RNA sequencing 
Massively parallel single-cell RNA sequencing of human bronchial airway 
cells was performed using a modified version of the CEL-Seq RNA library 
preparation protocol39. For each of the 12 recruited donors, one frozen 96-well 
PCR plate containing sorted cells was thawed on ice and RNA was directly 
reverse transcribed (ThermoFisher; AM1751) from whole cell lysate using 
primers composed of an anchored poly(dT), the 5’ Illumina adaptor sequence, a 




(UMI), and a T7 RNA polymerase promoter. Samples were additionally 
supplemented with ERCC RNA Spike-In mix (ThermoFisher; 4456740) 
(1:1,000,000 dilution) for quality control. cDNA generated from each of the 96 
cells per plate was pooled, subjected to second strand synthesis (ThermoFisher; 
AM1751) and amplified by in vitro transcription (ThermoFisher; AM1751). 
Amplified RNA was chemically fragmented (New England BioLabs; E6150) and 
ligated to the Illumina RNA 3’ adapter (Illumina RS-200-0012). Samples were 
again reverse transcribed using a 3’ adaptor-specific primer and amplified using 
indexed Illumina RNA PCR primers (Illumina RS-200-0012). In total, 1152 
samples (1008 epithelial cells, 132 white blood cells, 12 negative controls) were 
sequenced on an Illumina HiSeq 2500 in rapid mode, generating paired-end 
reads (15 nucleotides for Read 1, 7 nucleotides for index, 52 nucleotides for 
Read 2). 
Data preprocessing 
Illumina’s bcl2fastq2 software (v2.19.1) was used to de-multiplex the 
sequencing output to 12 plate-level FASTQ files (1 per 96-well plate). A python-
based pipeline (https://github.com/yanailab/CEL-Seq-pipeline) was utilized to: 1) 
de-multiplex each plate-level FASTQ file to 96 cell-level FASTQ files, trim 52 
nucleotide reads to 35 nucleotides, and append UMI information from read 1 (R1) 
to the header of read 2 (R2); 2) perform genomic alignment of R2 with Bowtie2 
(v2.2.2) using a concatenated hg19/ERCC reference assembly; and 3) convert 




(v0.5.4p1) python library that identifies reads aligning to the same location with 
identical UMIs and reduces them to a single count. One UMI-corrected count was 
then referred to as a “transcript”. The pipeline was configured with the following 
settings: alignment quality (min_bc_quality) = 10, barcode length (bc_length) = 6, 
UMI length (umi_length) = 5, cut_length = 35. 
Data quality control  
The quality of each cell was assessed by examining the total number of 
reads, total reads aligned to hg19, total reads aligning to genes (pre-UMI 
correction), total transcript counts, and total genes with at least one detected 
transcript. Cells were excluded from downstream analyses if the total number of 
transcripts were not two-fold greater than the total background-level transcripts 
detected in the empty well negative control on each plate (Figure 2.4A). Cells 
were also excluded from downstream analyses if there was a weak Pearson 
correlation (r < 0.7) between detected ERCC RNA Spike-in transcript counts 
(Log10) and ERCC input concentration (Log10) (amol/ml) (Figure 2.4B-D). All 
non-protein-coding genes and genes with less than 2 transcript counts in 5 cells 
were removed from the dataset. The remaining 7680 genes measured across 
796 cells were used for subsequent analyses. 
Latent Dirichlet allocation (LDA) implementation and model optimization 
Latent Dirichlet Allocation (LDA) (topicmodels R package v0.2-6) was 




present in the dataset, referred to as Cell-States and Gene-States (Figure 2.8). 
The input for the Cell-State model required a counts data matrix where cells were 
columns and genes were rows, whereas for the Gene-State model, the same 
matrix was transposed (ie. genes were columns and cells were rows). Models 
were fit using the Variational Expectation-Maximization (VEM) algorithm with the 
following parameters: nstart = 5, seed = 12345, estimate.alpha = TRUE, 
estimate.beta = TRUE. The given parameter “k” determined the number of Cell-
States and Gene-States to be estimated by the model. The optimal value of k 
was determined by 5-fold cross validation and evaluation of model perplexity. For 
the Gene-State model, cells were randomly partitioned into “training” (80%) and 
“test” (20%) sets, whereas for the Cell-State model, genes were randomly 
partitioned into “training” (80%) and “test” (20%) sets. Models were then fit to the 
training set and perplexity was estimated to evaluate model fit for the held out 
test set. Fifty iterations of this process were performed for k = 2-50, mean 
perplexity was calculated at each k, and the minimum mean perplexity was 
selected as the optimal value of k (ie. k.opt), which was k = 13 for the Cell-State 
model and k = 19 for the Gene-State model (Figure 2.9). 
Gene set (GS) and cell cluster (C) assignments 
Negative binomial generalized linear models were built using the MASS R 
package (v7.3-45) for each Gene-State (n=19) and each Cell-State (n=13), in 
which States were treated as independent variables and genes or cells, 




State if a significant association (FDR q < 0.05) was observed with positive 
directionality (regression coefficient > 1). A more stringent significance threshold 
was applied when assigning genes to Gene-States (FDR q < 1 x 10-5, regression 
coefficient > 1). If multiple State associations were observed for a given gene or 
cell, assignment was determined based on the strongest State association (ie. 
minimum FDR q). Additional metrics derived from Cell- and Gene-State models 
(generated using the R topicmodels package) include State Specificity and State 
Similarity. State Specificity was used to enrich for genes and cells that were 
specific to only one Gene-State or Cell-State, respectively. Briefly, for each 
Gene-State, the R topicmodels package generated a corresponding term 
distribution. All genes contributed to each term distribution, the sum of which was 
1 for each Gene-State. Term values indicated the fraction of the overall Gene-
State signal contributed by each gene. State Specificity therefore refers to the 
percentage of gene-specific signal allocated to each Gene-State. Similar logic 
was applied to Cell-States, their corresponding term distributions, and cell-
specific contributions to each. For both Gene- and Cell-State models, a minimum 
State Specificity of 0.1 was required for gene or cell assignment. However, a 
strong State Specificity measurement might be detected for a particular gene 
despite sparse gene expression. Therefore, an additional metric, State Similarity, 
was utilized for gene assignment in order to enrich for genes that were robustly 
expressed. State Similarity refers to cosine (q) similarity between the proportions 




Gene-State probability distribution. For Gene-State models only, a minimum 
State Similarity of 0.4 was required for gene assignment. All downstream 
analyses used the 785 cells that fit the criteria for Cell-State assignment and 676 
genes that fit the criteria for Gene-State assignment. 
Data visualization by heatmap and t-SNE 
Prior to heatmap visualization, transcript counts were transformed to z-
normalized transcripts per million (TPM). Genes (top-to-bottom) and cells (left-to-
right) were ordered according to the strength of statistical association (FDR q) 
with respective assigned Gene-States and Cell-States. The tsne R package v0.1-
3 was used for dimensionality reduction by t-distributed stochastic neighbor 
embedding (t-SNE). Modified parameters include: k = 2, seed = 1234. Input for t-
SNE was z-normalized transcripts per million (TPM) values across genes with at 
least 3 transcript counts in 3 cells (n = 5,300 genes). Gene expression overlay 
onto t-SNE visualization was also performed using z-normalized TPM values. 
Functional annotation  
The enrichR R package (v0.0.0.9000) was used as an interface for the 
web-based functional annotation tool, Enrichr, to identify Gene Ontology terms 
from the GO Biological Process 2015 library significantly associated with each 
gene set. 
Microarray data processing 




Series GSE7895 were normalized to produce gene-level expression values using 
the implementation of the Robust Multiarray Average (RMA) in the affy R 
package (v1.36.1) and an Entrez Gene-specific probeset mapping (17.0.0) from 
the Molecular and Behavioral Neuroscience Institute (Brainarray) at the 
University of Michigan (http://brainarray.mbni.med.umich.edu/). 
Comparative analysis of scRNA-Seq and microarray data 
Bronchial brushings were reconstructed in silico from the single cell data 
by taking the sum of all transcript counts for each gene across all cells procured 
from each donor. Negative binomial generalized linear models were built using 
the MASS R package (v7.3-45), modeling transcript counts as a function of 
smoking status (FDR q < 0.05: n=593 genes). Using only smoking-associated 
genes, correlations (Spearman) amongst reconstructed bronchial brushings were 
examined (Supplementary Figure 4A). In parallel, using never and current 
smoker bulk bronchial brushing microarray data (see Microarray analysis), linear 
models were built using the stats R package (R v3.2.0), modeling gene-level 
expression values as a function of smoking status (FDR q < 0.05: n=689 genes). 
The correlation between test statistics generated from both models was then 
measured to compare differential expression results (Supplementary Figure 
4B). Using the overlap amongst smoking-associated genes identified in both 
models (n=155 genes), correlations (Spearman) amongst in silico bronchial 






Transcript counts were transformed to z-normalized transcripts per million 
(TPM) and the mean z-score was computed across all genes in each gene set 
(GS) for each cell. For microarray data, RMA-transformed values for each gene 
were z-normalized and the mean z-score was computed across all genes in each 
gene set (GS) for each sample. 
Gene set analysis in microarray data 
Using published microarray data generated from bulk bronchial brushings 
procured from never and current smokers, MetaGene values were computed for 
each gene set (GS-1 to 19). For each MetaGene, differential expression between 
never and current smoker samples was assessed using the Wilcoxon Rank Sum 
(WRS) test. For each smoking-associated MetaGene (p < 0.05), if the mean 
current smoker value was greater than- or less than- the mean never smoker 
value, the gene set was considered to be up- or down-regulated in current 
smokers, respectively. 
Assignment of cell types to cell clusters 
TPM values for cell type marker genes (KRT5, FOXJ1, SCGB1A1, 
MUC5AC, and CD45) were z-normalized across all cells. Cluster-specific mean 
expression was designated: high (pink) if expression exceeded one standard 
deviation above the mean value across all cells; medium (white) if expression 




low (light grey) if expression exceeded the mean value across all cells. If cluster-
specific mean expression was designated high, medium, or low for KRT5, 
FOXJ1, SCGB1A1, MUC5AC, or CD45 (PTPRC), that cluster was assigned the 
cell type of basal, ciliated, club, goblet, or white blood cell, respectively. Cluster-
specific mean expression below the mean value across all cells indicated that a 
given cluster did not express a given marker gene (dark grey). 
Assignment of gene sets to cell clusters 
A MetaGene was generated for each gene set (GS-1 to 19). Cluster-
specific MetaGene expression was designated: high (pink) if mean expression 
exceeded one standard deviation above the mean value across all cells; medium 
(white) if mean expression exceeded one half of a standard deviation above the 
mean value across all cells; low (light grey) if mean expression exceeded the 
mean value across all cells. Cluster-specific mean expression below the mean 
value across all cells indicated that a given cluster did not express a given gene 
set (dark grey). 
Bronchial tissue collection for immunostaining 
Bronchial tissue was collected from patients undergoing lung resection.  
All specimens were procured at least 5 cm from bronchial sites affected by 
disease diagnoses and analyses indicated that tissue was histologically normal. 
CohortUCL included specimens analyzed in collaboration with University College 




was sought and obtained from University College London (UCL) Hospital 
Research Ethics Committee (REC reference 06/Q0505/12). This study was 
carried out in accordance with the Declaration of Helsinki (2000) of the World 
Medical Association. CohortUMCG included specimens analyzed in collaboration 
with University Medical Center Groningen (UMCG) collected from 4 never 
smokers and 4 current smokers. Specimens were obtained from the tissue bank 
in the UMCG Department of Pathology. The study protocol was consistent with 
the Research Code of the University Medical Center Groningen and Dutch 
national ethical and professional guidelines (“Code of conduct; Dutch federation 
of biomedical scientific societies”; http://www.federa.org). 
Immunofluorescence 
Formalin-fixed paraffin-embedded lung sections were cut at 4 µm. Tissue 
was incubated with primary antibodies (listed below), probed with secondary 
antibodies with fluorescent conjugates (Invitrogen Alexa Fluor 488, 594, 647), 
and nuclear staining was performed with DAPI (ThermoFisher; R37606). 
Immunostaining was performed using the following primary antibodies: mouse 
anti-Acetylated-a-Tubulin (Ac-a-Tub) (Sigma; T6793) (Sigma), rabbit anti-
Acetylated-a-Tubulin (Ac-a-Tub) (Enzo Life Sciences; BML SA4592), rabbit anti-
AKR1B10 (Sigma; HPA020280), rabbit anti-CEACAM5 (Abcam; ab131070), 
mouse anti-FOXJ1 (eBioscience; 14-9965-82), chicken anti-KRT5 (BioLegend; 
905-901), rat anti-KRT8 (Developmental Studies Hybridoma Bank, University of 




(Sigma; HPA008246). Imaging of staining panels analyzed in collaboration with 
investigators at University College London using CohortUCL (e.g. CEACAM5 / 
KRT8 / MUC5AC, Figure 6D; FOXJ1 / Ac-a-Tub / KRT8, Supplementary Figure 
13; KRT8 / MUC5AC / Ac-a-Tub, Supplementary Figure 21-22) was performed 
using a Leica TCS Tandem confocal microscope at 63x objective magnification. 
Imaging of staining panels analyzed in collaboration with investigators at 
University Medical Center Groningen using CohortUMCG (e.g. AKR1B10 / Ac-a-
Tub / KRT8, Figure 4D; AKR1B10 / MUC5AC / KRT8, Supplementary Figure; 
MUC5B / MUC5AC, Figure 5B; MUC5B / MUC5AC / KRT5, Supplementary 
Figure 20) was performed using a Carl Zeiss LSM 710 NLO confocal microscope 
at 63x objective magnification at the Boston University School of Medicine 
Multiphoton Microscope Core Facility. 
Immunohistochemistry 
Formalin-fixed paraffin-embedded lung sections were cut at 4 μm. Citrate 
buffer (pH 6.0, Sigma) was used for antigen retrieval, tissue was stained with 
Alcian blue, then probed with antibodies as follows: rabbit anti-CEACAM5 
(Abcam; ab131070) primary antibody, followed by peroxidase-labeled anti-rabbit 
secondary antibody, and DAB staining; rat anti-KRT8 (Developmental Studies 
Hybridoma Bank, University of Iowa; TROMA-I) primary antibody, followed by 
peroxidase-labeled anti-rat secondary antibody, and NovaRED staining (Vector 






All imaging data was analyzed using ImageJ Fiji software and whole slide 
immunohistochemistry images were processed using the NDPITools plugin. For 
each image, cells were counted relative to the measured length of the epithelium 
in microns (cells/µm). Mean cell counts per micron (cells/µm) was then calculated 
for never smokers (treated as the control) and individual values for each image 
from never and current smokers were calculated relative to the never smoker 
mean (i.e. relative cells/µm). We analyzed three images for each donor and 
assessed smoking-associated changes using the Wilcoxon rank-sum test. For 
panels in which MUC5AC was stained, current smoker tissue was assigned 
phenotypic status of either “morphologically normal” (MN) or “goblet cell 
hyperplasia” (GCH), based on qualitative assessment of goblet cell density and 




Single-cell RNA-Seq was used to identify bronchial subpopulations in the 
airways of never and current smokers 
Tissue was procured by bronchoscopic cytobrushing of the right mainstem 
bronchus from healthy current smokers (n=6) and from healthy never smokers 
(n=6) (Figure 2.1, Table 1). Recent smoke exposure in current smokers and lack 




exhaled carbon monoxide as well as urine cotinine levels (Table 1). The 
transcriptomes of single ALCAM+ epithelial cells40 (n = 84) and CD45+ white 
blood cells (WBCs) (n=11) (95 total cells) isolated (Figure 2.2) from each of the 
12 donors (1140 cells total: 1008 epithelial cells and 132 WBCs) were profiled by 
single-cell RNA sequencing (scRNA-Seq) using CEL-seq39. Low quality cells 
were excluded from downstream analyses, leaving 796 cells (753 epithelial cells, 
43 WBCs) (Figure 2.3-2.4). An average of 1817 genes were detected per cell 
after filtering. Analysis of bronchial brushings reconstructed in silico from the 
single cell data indicated that smoking-associated differential expression was 
similar to that observed in microarray data21 generated from bulk bronchial 
brushings procured from a larger cohort of never and current smokers (test 
statistic Spearman’s r = 0.45) (Figure 2.5). 
Across all cells, marker genes for known bronchial cell types including 
KRT5 for basal cells, FOXJ1 for ciliated cells, SCGB1A1 for club cells, MUC5AC 
for goblet cells, and CD45 for white blood cells had distinct expression patterns 
(Figure 2.6). We then utilized Latent Dirichlet Allocation (LDA) as an 
unsupervised framework to assign cells to clusters, regardless of smoking status, 
and to identify distinct sets of co-expressed genes across all cells. LDA divided 
the dataset into 13 distinct cell clusters and 19 sets of co-expressed genes 
(Figure 2.7A, Figure 2.8-2.9). Each cell cluster was defined by the expression of 
a unique combination of gene sets and each gene set was defined by a unique 




sets were specifically expressed by one cell cluster, whereas others were shared 
across multiple cell clusters. Cell types were defined for 9 of the 13 clusters 
based on medium to high marker gene expression: cell clusters C-2 and C-4 
expressed KRT5, C-5 and C-11 expressed FOXJ1, C-1 and C-8 expressed 
SCGB1A1, and C-3 expressed MUC5AC (Figure 2.7B). Cluster C-7 expressed 
WBC marker CD45 (Figure 2.7B) and Fisher’s exact test (FET) was used to 
show that C-7 was enriched with sorted CD45+ cells (FET p = 9.6 x 10-47). Low 
levels of SCGB1A1 transcripts were detected in cluster C-10 and therefore, these 
cells were referred to as SCGB1A1low (Figure 2.7B). Clusters C-6, C-9, C-12, 
and C-13 did not express high levels of cell type marker genes (Figure 2.7B). 
Enrichment of current smoker cells was observed in MUC5AC+ cluster C-3 
(FET p = 3.9 x 10-20), C-9 (FET p = 1.6 x 10-33), and C-12 (FET p = 5.8 x 10-4), as 
well as C-6 (FET p = 0.02), which only contained 5 cells (Figure 2.7C). 
Conversely, enrichment of never smoker cells was observed in SCGB1A1+ 
cluster C-1 (FET p = 8.9 x 10-24), SCGB1A1low cluster C-10 (FET p = 9.2 x 10-4), 
and KRT5+ clusters C-2 (FET p = 9.3 x 10-3) and C-4 (FET p = 5.9 x 10-11) 
(Figure 2.7C). No smoking status-specific cell enrichment was observed in 
FOXJ1+ clusters C-5 and C-11, CD45+ cluster C-7, SCGB1A1+ cluster C-8, and 
unknown cluster C-13. Examination of published microarray data21 generated 
from never and current smokers indicated that several of the identified gene sets 
were differentially expressed (Wilcoxon Rank-Sum (WRS) p < 0.05) in bulk 




were up-regulated in current smokers, whereas GS-3, GS-4, GS-10, GS-17, GS-
18, GS-19 were down-regulated in current smokers (Figure 2.7D). Most of the 
differentially expressed gene sets were detected in either basal, ciliated, club, or 
goblet cells, which suggested that smoking-associated gene expression changes 





Table 1. Bronchial brushings were procured from 6 never smokers and 6 
current smokers. 
Never and current smoker donors were healthy volunteers recruited at Boston 
University Medical Center (BUMC). In addition to bronchoscopy and procurement 
of bronchial brushing, spirometry was performed to assess lung function by 
measuring forced expiratory volume in one second (FEV1) relative to forced vital 
capacity (FVC). Exhaled carbon monoxide (CO) and urine cotinine levels were 





Figure 2.1 - Single cell RNA sequencing of human bronchial cells from 
never and current smokers.  
(A) Bronchial brushings were procured from the right mainstem bronchus of 6 
never smokers and 6 current smokers. Bronchial tissue was dissociated, single 
cells were isolated by FACS, single cell RNA libraries were prepared (CEL-Seq) 
and sequenced, and an unsupervised analysis was performed by Latent Dirichlet 
Allocation (LDA). (B) Distinct cell clusters and gene sets were identified and each 
cell cluster was defined as a unique combination of gene sets. Associations with 





Figure 2.2 - Single bronchial cells were isolated by FACS.  
(A) Gating based on forward scatter height vs. forward scatter area (FSC-H vs. 
FSC-A) was applied to sort only singlet events (single cells). (B) Red blood cells 
expressing GYPA/B on their surface were stained and excluded. (C) Epithelial 
cells expressing ALCAM on their surface and white blood cells (WBCs) 
expressing CD45 on their surface were stained and sorted. (D) Staining cells for 
surface expression of both ALCAM and EPCAM indicated that ALCAM+ epithelial 





Figure 2.3 - Single cell RNA-Seq data quality was evaluated for each donor.  
For each cell from each donor, numbers of total reads (A), reads that mapped to 
hg19 (B), reads that mapped to genes (pre-UMI correction) (C), transcript counts 






Figure 2.4 - Low quality cells were excluded from downstream analyses.  
Figures A-D are depicting data from a single donor: 84 epithelial cells (green), 11 
WBCs (blue), and 1 empty well negative control (pink). (A) Total transcript counts 
for each cell were plotted and those with less than 2-fold the background-level 
counts detected in the empty well negative control (grey) were excluded from 
subsequent analyses. (B) Pearson correlation between detected ERCC RNA 
Spike-in transcript counts (Log10) and ERCC input concentration (Log10) (amol/µl) 
was plotted for each. Cells in which a weak correlation (r < 0.7) was observed 
were excluded from subsequent analyses. Examples of cells with (C) strong (r = 
0.87) and (D) weak (r = 0.41) correlations between detected ERCC transcript 





Figure 2.5 - Bronchial brushings reconstructed in silico from single cell 
data resembled data generated from bulk bronchial brushings.  
For each donor, bronchial brushings were reconstructed in silico by combining 
data from all profiled cells. (A) Spearman correlations amongst in silico bronchial 
brushings were displayed by heatmap (weak correlation = white, strong 
correlation = green). (B) Differential expression between never and current 
smoker in silico bronchial brushings was compared to a similar analysis 
performed using published microarray data generated from bulk bronchial 
brushings. The correlation amongst test statistics generated from the two 
differential expression analyses was assessed. (C) Spearman correlations 
amongst in silico bronchial brushings and bulk bronchial brushing data were 





Figure 2.6 - Expression patterns of bronchial cell type marker genes across 
cells from never and current smokers.  
t-Distributed Stochastic Neighbor Embedding (t-SNE) was performed to illustrate 
transcriptomic relationships amongst cells. (A) t-SNE was used to visualize donor 
smoking status (NS = never smoker = grey; CS = current smoker = black) for 
each cell as well as (B-F) expression of bronchial cell type marker genes (z-
normalized transcripts per million (TPM) values) across all cells: (B) KRT5 






Figure 2.7 - Transcriptomic characterization and assessment of bronchial 
cluster cell type and smoking status.  
(A) Global transcriptomic profiles of 13 bronchial cell clusters were defined by 
expression of unique combinations of 19 gene sets and visualized by heatmap 
(z-normalized TPM values). To the right of each gene set label on the heatmap, 
colors indicate clusters that exhibit high expression of each gene set, which 
corresponds to data presented in Supplementary Figure 9. (B) Mean expression 
of marker genes was summarized for each cluster and expression levels were 
assigned the status of high (pink), medium (white), low (light grey), or not 




never (grey) and current (black) smoker cells was calculated. Fisher’s exact test 
(FET) was used to assess per cluster statistical enrichment of never or current 
smoker cells. (D) Mean MetaGene expression of GS-1:19 across all never 
smokers and all current smokers in published microarray data generated from 
bulk bronchial brushings procured from never and current smokers indicated that 
GS-1, GS-8, GS-12, GS-15, and GS-16 were up-regulated in current smokers, 






Figure 2.8 - Latent Dirichlet Allocation (LDA) was used identify Cell-States 
and Gene-States.  
(A) Model input for LDA was a data matrix containing transcript counts for which 
there was no a priori knowledge of expected cell clusters or gene sets (rows = 
Genes A-H, columns = Cells 1-8) (low expression = white, high expression = 
red). (B) LDA was used to generate probabilistic representations (low probability 
= 0 = white, high probability = 1 = blue) of the types of genes present in the 
dataset, referred to as Gene-States (n=4: I-IV). (C) LDA was used to generate 
probabilistic representations (low probability = 0 = white, high probability = 1 = 






Figure 2.9 - Cross validation was performed to determine optimal Cell-State 
and Gene-State models.  
To determine the optimal number (k.opt) of Gene-States and Cell-States, model 
perplexity was evaluated for 50 iterations of 5-fold cross validation at k = 2-50. 
(A) For Gene-State models, mean perplexity was calculated across all iterations 
and plotted for each value of k. The minimum mean perplexity value was 
selected as k.opt (k = 19). (B) For Cell-State models, mean perplexity was 
calculated across all iterations and plotted for each value of k. The minimum 





Figure 2.10 - Gene set expression was assessed in each cluster.  
A MetaGene was generated for each gene set (GS-1 to 19) and violin plots (A-S) 
were used to display the distribution of MetaGene expression values amongst 




(pink), medium (white), low (light grey), or not expressed (dark grey). Horizontal 
dotted lines in each plot designated: mean expression across all cells (bottom), 
one half of a standard deviation above the mean value across all cells (middle), 





A cell type-specific transcriptional response to toxin exposure was 
detected in smoker ciliated cells 
Our data suggested that there were no smoking-associated changes in 
the abundance of either FOXJ1+ ciliated cell clusters (C-5 and C-11). FOXJ1 was 
detected in gene set GS-2 and shared by cell clusters C-5 and C-11. GS-2 was 
enriched with genes involved with ciliary assembly, maintenance, and function, 
such as motor protein genes (e.g. DYNLL1, DNAH9) and intraflaggelar transport 
genes (e.g. IFT57, IFT172), as well as TUBA1A, which encodes the tubulin 
subunit that forms the primary ciliary structure (Figure 2.11A). GS-2 also 
includes anti-oxidant genes (e.g. PRDX5, GPX4, GSTA2), known transcriptional 
regulators of ciliogenesis (e.g. RFX241-42, RFX343-44), and surface proteins not 
previously attributed to ciliated cells (e.g. CDHR3, CD59). Expression of GS-2 
genes was not affected by smoking status (Figure 2.12A,D). 
Specific expression of gene set GS-3 differentiated C-5 from C-11 ciliated 
cells (Figure 2.11A). Genes with known roles in airway ciliary biology were 
identified in GS-3, such as IFT8845-47, which is required for ciliary formation, and 
DNAH548-50, which is required for ciliary motility. Surface proteins PROM1 and 
CDHR4 were also identified as highly specific to the C-5 cluster of ciliated cells 
and a subtle, but significant decrease in GS-3 gene expression was observed in 
current smoker C-5 cells, relative to never smoker cells (WRS p = 3.9 x 10-5; 
Figure 2.12B). C-11 cells could be differentiated from C-5 cells based on specific 




2.11A, Figure 2.12E). Expression of transcription factor, HES6, was detected in 
GS-7 and used to define cluster C-11 cells as FOXJ1+ HES6+. Cell cycle-related 
genes were also found in GS-7, such as CDK1 and CCNB1, which mediate the 
G1/S transition, and TOP2A, which enzymatically facilitates S-phase DNA 
replication. GS-7 expression, including HES6, was also detected in cluster C-13 
cells, which suggests that there may be a functional relationship to FOXJ1+ 
HES6+ cells, but no known ciliated cell-specific genes were detected in this 
cluster.  
Gene set GS-8 was significantly up-regulated (WRS p = 4.1 x 10-15) in 
current smoker FOXJ1+ cells (C-5 and C-11), relative to never smoker cells 
(Figure 2.11B, Figure 2.12C,F). We found that GS-8 was enriched with genes 
encoding enzymes implicated in aldehyde and ketone metabolism, such as 
ALDH3A1, AKR1C1, and AKR1B10 (Figure 2.11B-C). Therefore, the data 
suggested that smoke-derived toxic aldehydes and ketones might elicit a ciliated 
cell-specific metabolic coping mechanism. To confirm that this set of 
detoxification enzymes localized to ciliated cells, we immunostained bronchial 
tissue procured at University Medical Center Groningen (UMCG) from an 
independent cohort of never and current smokers (Table 3) for expression of an 
aldo-keto reductase, AKR1B10 (Figure 2.11D). We found that AKR1B10 was 
robustly expressed in the airways of current smokers and numbers of AKR1B10+ 
ciliated cells were significantly higher than those observed in never smokers 




cytoplasm of smoker ciliated cells, as well as at the base of the cilia (Figure 
2.11D). AKR1B10+ ciliated cells were uncommon in never smokers and overall 
low magnitude of AKR1B10 expression was observed (Figure 2.11D). We 
detected rare instances of non-ciliated AKR1B10+ KRT8+ cells (Figure 2.13A), 
but AKR1B10+ KRT8- cells were not observed. We also confirmed that AKR1B10 





Table 2. Bronchial tissue was obtained by lung resection from 4 never 
smokers and 4 current smokers at University Medical Center Groningen. 
Lung resection was performed at University Medical Center Groningen (UMCG) 
on never and current smoker patients diagnosed with one of the following: lung 
adenocarcinoma (ADC), lung squamous cell carcinoma (SCC), pulmonary 
carcinoid (PC), metastasis (MET), or inflammatory myofibroblastic tumour (IMT). 
Spirometry was also performed to assess lung function by measuring forced 





Figure 2.11 - A ciliated cell-specific detoxification program was observed in 
the airways of current smokers.  
(A) Expression of gene sets GS-2, GS-3, and GS-7 in clusters C-5 and C-11 was 
visualized by heatmap (z-normalized TPM values). (B) Cluster C-5 was split into 
never and current smoker subsets. GS-8 expression was significantly higher in 
cells from current smokers. (C) t-SNE was used to visualize AKR1B10 
expression (z-normalized TPM values) across all cells and cluster C-5 cells were 
outlined in yellow. (D) Bronchial tissue procured at UMCG from an independent 
cohort of never and current smokers was immunostained for AKR1B10, 
Acetylated alpha tubulin (Ac-a-Tub), and KRT8. Representative images of never 
smoker (left) and current smoker (right) tissue were displayed. Arrows indicate 
ciliated cell (Ac-a-Tub+)-specific expression of AKR1B10. (E) Changes in tissue 
length (µm)-normalized numbers of AKR1B10+ Ac-a-Tub+ cells in current 





Figure 2.12 - Differential expression of ciliated cell-specific gene sets was 
observed in current smoker ciliated cells.  
Violin plots were used to display the distribution of gene set MetaGene 
expression values amongst never and current smoker cells in clusters C-5 and 
C-11. Horizontal dotted lines designated: mean never smoker expression 
(middle), as well as one standard deviation above (top) and below (bottom) the 
never smoker mean value. Cluster C-5 was divided into never and current 
smoker subsets and differential expression was assessed by WRS test for (A) 
the gene set GS-2 MetaGene (p = 0.97), (B) the GS-3 MetaGene (p = 3.9 x 10-5), 
and (C) GS-8 MetaGene (p = 4.1 x 10-15). Cluster C-11 was divided into never 
and current smoker subsets and differential expression was assessed by WRS 
test for (D) the gene set GS-2 MetaGene (p = 0.45), (E) the GS-7 MetaGene (p = 





Figure 2.13 - Non-ciliated cell AKR1B10 expression was uncommon. 
(A) Immunostaining for AKR1B10, Acetylated alpha tubulin (Ac-a-Tub), and 
KRT8 was performed using bronchial tissue from an independent cohortUMCG of 
never and current smokers. A representative image of current smoker (right) 
tissue was displayed. An arrow was used to specify an example of a non-ciliated 
(Ac-a-Tub-) KRT8+ AKR1B10+ cell. (B) Immunostaining for AKR1B10, MUC5AC 
(goblet), and KRT8 was performed using bronchial tissue procured at UMCG 
from an independent cohort of never and current smoker donors. A 
representative image of current smoker (right) tissue was displayed. Arrows were 






Goblet cell expansion and club cell depletion was observed in the airways 
of smokers 
Prior studies have shown that smoking is associated with increased 
bronchial goblet cell abundance9-11. Our data is consistent with these findings 
and we also observed a concurrent smoking-associated loss of club cells. 
Specifically, MUC5AC+ cluster C-3 was significantly enriched with current smoker 
cells, whereas the largest SCGB1A1+ cluster (C-1) was enriched with never 
smoker cells (Figure 2.7B, 2.14A). An additional cluster of SCGB1A1+ cells (C-8) 
was identified, but no smoking status association was observed. Both C-1 and C-
8 club cells expressed GS-17, which contained the club cell marker gene, 
SCGB1A1 (Figure 2.14A). Cluster C-1, however, distinctly expressed high levels 
of GS-19 genes, which contained MUC5B, as well as SCGB3A1 and 
transcription factors TCF7, FOS, and JUN (Figure 2.14A). Therefore, we defined 
clusters C-1 and C-8 as SCGB1A1+ MUC5B+ and SCGB1A1+ MUC5B-, 
respectively. We also identified a never smoker cell-enriched cluster of 
SCGB1A1low cells (C-10) that co-expressed gene set GS-10 with SCGB1A1+ 
MUC5B+ cells (Figure 2.7B, Figure 2.10). Low expression of SCGB1A1 
suggests that cluster C-10 may be club-like, but co-expression of gene set GS-6 
(enriched with antigen presentation genes) with other, non-club clusters (C-9 and 
C-12) indicate that it is functionally distinct from SCGB1A1+ MUC5B+ and 
SCGB1A1+ MUC5B- cells. 




contained the goblet cell marker gene, MUC5AC, as well as several genes with 
known roles in goblet cell biology, such as SPDEF51, AGR252, and TFF353 
(Figure 2.14A). Genes associated with the unfolded protein response (UPR) 
were detected in GS-1 (e.g. KDLER3, DNAJC10). We also identified several 
unique goblet cell surface markers (e.g. TSPAN8, TSPAN13), as well as a 
transcription factor (NKX3-1) whose role in the goblet cell transcriptional program 
is unknown (Figure 2.14A). MUC5AC+ cells (C-3) additionally expressed high 
levels of GS-13, which contained several immunologically relevant genes (e.g. 
BPIFB1, PIGR, FCGBP) (Figure 2.14A). Mid-level expression of GS-13 was also 
detected in SCGB1A1+ MUC5B+ (C-1) and SCGB1A1+ MUC5B- (C-8) cells 
(Figure 2.14A), as well as in SCGB1A1low cells (C-10) and cluster C-12 (Figure 
2.10). 
To confirm smoking-associated shifts in club and goblet cell abundance, 
we immunostained bronchial tissue procured at UCMG from an independent 
cohort of never and current smokers (Table 3) for MUC5B and MUC5AC 
expression. MUC5B was used as never smoker-specific surrogate marker for 
club cells. Results indicated that morphologically similar cells expressed MUC5B 
and MUC5AC (Figure 2.14B). High expression of either MUC5B or MUC5AC 
was indicative of distinct cell subpopulations in many cases (MUC5Bhigh 
MUC5AClow cells were assigned MUC5B+ status and MUC5AChigh MUC5Blow 
cells were assigned MUC5AC+ status), but co-expression of MUC5B and 




(Figure 2.14B). The airways of never smokers contained similar numbers of 
MUC5B+, MUC5B+ MUC5AC+, and MUC5AC+ cells (Figure 2.14F). The 
bronchial epithelium of smokers, however, took on two distinct phenotypes: 
regions described as “morphologically normal” (MN) (similar to those of never 
smokers) and regions with goblet cell hyperplasia (GCH). The epithelium of 
smoker GCH tissue was specifically characterized by high MUC5AC+ cell density 
(Figure 2.14B). In the MN smoker tissue, we observed a significant decrease in 
MUC5B+ cells (WRS p = 0.02) and a significant increase in MUC5AC+ cells 
(WRS p = 1.5 x 10-6), relative to never smokers (Figure 2.14C,E), but no change 
in MUC5B+ MUC5AC+ content was observed (Figure 2.14D). Differences 
between smoker GCH and never smoker epithelium, however, were more 
severe. Near complete loss of MUC5B+ cells was observed in smoker GCH (p = 
1.8 x 10-5; Figure 2.14C), along with a significant loss of MUC5B+ MUC5AC+ 
cells (p = 0.02; Figure 2.14D), relative to never smokers. GCH-associated 
alterations were accompanied by a 13-fold increase in MUC5AC+ cells (p = 7.4 x 
10-7; Figure 2.14E-F). 
Never smoker cell enrichment in both KRT5+ clusters (C-2 and C-4) 
suggested that there might also be a smoking-associated loss of basal cells 
(Figure 2.7C). To examine basal cell content in the context of both MN and GCH 
smoker tissue regions, the same bronchial tissue from never and current 
smokers that we immunostained for MUC5B and MUC5AC expression (Figure 




proportion of basal cells, relative to goblet cells, was significantly reduced in MN 
(WRS p = 1.5 x 10-6) and GCH (WRS p = 3.6 x 10-5) tissue (Figure 2.15C). 
However, absolute KRT5+ cell numbers were not affected by smoking status 
(WRS p = 0.2 for MN and GCH; Figure 2.15B). Qualitative assessment revealed 
consistent basal layer disorganization in GCH smoker regions, but the functional 





Figure 2.14 - Increased numbers of goblet cells and decreased numbers of 
club cells were associated with smoking status. 
(A) Expression of gene sets GS-19, GS-17, GS-13, and GS-1 in clusters C-1, C-
8, and C-3 was visualized by heatmap (z-normalized TPM values). Bronchial 
tissue procured at UMCG from an independent cohort of never and current 
smoker donors was immunstained for MUC5B and MUC5AC. (B) Representative 
images of never smoker tissue (left), morphologically normal (MN) current 
smoker tissue (middle), and current smoker goblet cell hyperplasia (GCH) (right) 
were displayed. Changes in tissue length (µm)-normalized numbers of (C) 
MUC5B+ (D) MUC5B+ MUC5AC+, and (E) MUC5AC+ cells in current smoker 
morphologically normal and GCH tissue were assessed relative to never 
smokers by WRS test. (F) Proportions of MUC5B+, MUC5B+ MUC5AC+, and 
MUC5AC+ cells were examined in never smokers, as well as MN and GCH 





Figure 2.15 - Basal cell proportions were reduced in smokers. 
Immunostaining for KRT5, MUC5AC, and MUC5B was performed using 
bronchial tissue procured at UMCG from an independent cohort of never and 
current smokers. (A) Representative images of never smoker tissue (left), as well 
as morphologically normal (MN) (middle) and goblet cell hyperplasia (GCH) 
(right) current smoker tissue were displayed. (B) Changes in tissue length (µm)-
normalized numbers of KRT5+ cells in MN and GCH current smoker tissue, 
relative to never smokers, were assessed by WRS test (MN p = 0.2; GCH p = 
0.2). (C) Changes in the proportion of KRT5+ cells, relative to MUC5AC+ goblet 
cells, in MN and GCH smoker tissue, relative to never smokers, were assessed 
by WRS test (MN p = 1.5 x 10-6; GCH p = 3.6 x 10-5). (D) Proportions of KRT5+ 
cells, MUC5B+ cells, MUC5B+ MUC5AC+ cells, and MUC5AC+ cells, were also 





A novel subpopulation of CEACAM5+ KRT8+ epithelial cells was observed 
in smokers 
We found that current smoker cell-enriched cluster C-9 expressed high 
levels of KRT8 (GS-12) (Figure 2.16A-B), but did not express bronchial epithelial 
cell type marker genes (e.g. KRT5, FOXJ1, SCGB1A1, MUC5AC) (Figure 2.7B). 
Immunostaining bronchial tissue procured at University College London (UCL) 
from an independent cohort of never and current smokers for KRT8, MUC5AC 
(goblet), and Ac-a-Tub (ciliated) revealed a subpopulation of KRT8+ MUC5AC- 
Ac-a-Tub- cells, detection of which was significantly higher in GCH regions of 
smoker bronchial tissue, relative to never smokers (Figure 2.16C-D). KRT8+ 
MUC5AC- Ac-a-Tub- cells were interpreted as an indeterminate subpopulation 
that was morphologically distinct from goblet and ciliated cells and typically found 
in close proximity to goblet cells (Figure 2.16C). 
Due to its broad, luminal expression in the epithelium, KRT8 alone could 
not be used to clearly specify the identity of cluster C-9. In addition to KRT8, 
gene set GS-12 contained several additional keratins (e.g. KRT19, KRT13), as 
well as anti-oxidant genes, such as TXN and GPX1 (Figure 2.17A). Cluster C-9 
also expressed gene set GS-16, which was detected at low levels in MUC5AC+ 
cells (C-3) and contained xenobiotic metabolism gene, CYP1B1 (Figure 2.17A). 
Furthermore, high expression of gene set GS-15 was detected in both C-9 cells 
and MUC5AC+ cells (C-3) (Figure 2.17A), suggesting that this cluster may have 




previously reported to be persistently up-regulated post-smoking cessation (e.g. 
CEACAM5, CEACAM6, UPK1B), one of which has been explicitly linked to lung 
squamous cell carcinoma and premalignancy (CEACAM5)54. 
To confirm that cluster C-9 represented the identified KRT8+ indeterminate 
subpopulation, we immunostained bronchial tissue procured at UCL from an 
independent cohort of never and current smokers (Table 2) for CEACAM5 
expression (Figure 2.17D). Co-staining the tissue for KRT8 and MUC5AC 
expression indicated that CEACAM5+ KRT8+ MUC5AC- cells were distinct from 
goblet cells (CEACAM5+ KRT8+ MUC5AC+), although often found in close 
proximity, and significantly more abundant in GCH regions of current smoker 
tissue, relative to never smokers (WRS p = 0.004) (Figure 2.17D-E). CEACAM5 
expression in goblet cells was phenotypically punctate and co-localized with 
MUC5AC in both never and current smokers (Figure 2.17D). In CEACAM5+ 
KRT8+ MUC5AC- cells, however, CEACAM5 distinctively localized to the cell 
surface and nucleus (Figure 2.17D). Observations were confirmed by 
immunohistochemical staining of bronchial tissue procured at UCMG from an 





Table 3. Bronchial tissue was obtained by lung resection from 5 never 
smokers and 5 current smokers at University College London Hospital.  
Lung resection was performed at University College London (UCL) Hospital on 
never and current smoker patients diagnosed with one of the following: lung 
adenocarcinoma (ADC), lung squamous cell carcinoma (SCC), basaloid 
carcinoma (BC), pulmonary carcinoid (PC), or pulmonary aspergilloma (PA). All 
specimens were procured at least 5 cm from bronchial sites affected by disease 






Figure 2.16 - Increased numbers of indeterminate KRT8+ cells were 
observed in goblet cell hyperplasia smoker tissue. 
(A) t-SNE was used to visualize cluster C-3 (blue) and C-9 (purple) cells as well 
as (B) CEACAM5 expression (z-normalized TPM values) across all cells. 
Immunostaining for KRT8, MUC5AC, and Acetylated alpha tubulin (Ac-a-Tub), 
was performed using bronchial tissue procured at UCL from an independent 
cohort of never and current smokers. (C) Representative images of never smoker 
(left) and goblet cell hyperplasia (GCH) current smoker (right) tissue were 
displayed. Arrows were used to specify examples of KRT8+ MUC5AC- Ac-a-Tub- 
cells. (D) Changes in tissue length (µm)-normalized numbers of KRT8+ MUC5AC- 
Ac-a-Tub- cells in GCH current smoker tissue, relative to never smokers, were 





Figure 2.17 - A previously uncharacterized subpopulation of CEACAM5+ 
KRT8+ cells was identified in the airways of smokers. 
(A) Expression of gene sets GS-12, GS-16, GS-15, and MUC5AC in clusters C-3 
and C-9 was visualized by heatmap (z-normalized TPM values). (B) t-SNE was 
used to visualize cluster C-3 and C-9 cells as well as (C) CEACAM5 expression 
(z-normalized TPM values) across all cells. (D) Bronchial tissue procured at UCL 
from an independent cohort of never and current smoker donors was 
immunostained for CEACAM5, KRT8, and MUC5AC. Representative images of 
never smoker tissue (left), morphologically normal current smoker tissue 
(middle), and current smoker goblet cell hyperplasia (GCH) (right) were 
displayed. Changes in tissue length (µm)-normalized numbers of (E) CEACAM5+ 
KRT8+ MUC5AC- cells in current smoker morphologically normal and GCH tissue 





Figure 2.18 - Increased numbers of CEACAM5+ non-goblets cells were 
detected by immunohistochemistry in goblet cell hyperplasia smoker 
tissue in an additional cohort. 
Immunohistochemistry staining for CEACAM5 and KRT8 in conjunction with 
Alcian blue staining (goblet) was performed using bronchial tissue procured at 
UMCG from an independent cohort of never and current smokers. (A) 
Representative images of never smoker (left) and goblet cell hyperplasia (GCH) 
current smoker (right) tissue were displayed. Arrows were used to specify 
examples of CEACAM5+ Alcian blue- cells. (B) Changes in tissue length (µm)-
normalized numbers of CEACAM5+ Alcian blue- cells in GCH current smoker 






Previous transcriptomic studies have shown that smoking is associated 
with a robust bronchial gene expression signature30-31. Interrogation of bronchial 
tissue at single cell resolution revealed that elements of this signature were 
derived from different cell subpopulations. Overall, we described smoking-
associated phenotypes that included a metabolic response that localized to 
ciliated cells, a cell type shift that involved club cell loss and goblet cell 
expansion, and a previously uncharacterized epithelial subpopulation that 
emerged alongside goblet cell hyperplasia. 
We identified a gene set (GS-8) specifically expressed by smoker ciliated 
cells (C-5) that contains genes encoding families of enzymes, such as aldehyde 
dehydrogenases (e.g. ALDH3A1, ALDH1A3) and aldo-keto reductases (e.g. 
AKR1B10, AKR1C1), capable of breaking down tobacco smoke-derived chemical 
compounds, such as toxic aldehydes (e.g. formaldehyde, acrolein) and ketones 
(e.g. acetone, methyl vinyl ketone)35-36. This finding suggests that ciliated cells 
play an important role in coping with smoking-associated toxicity. However, the 
extent to which this mechanism contributes to tissue maintenance, the viability of 
neighboring cells, and normal homeostasis is unknown. Furthermore, we did not 
assess the relationship between ciliated cell metabolic activity and previously 
reported smoking phenotypes, such as reduced ciliary length. Down-regulation of 
genes (GS-3), such as IFT8845-47 and DNAH548-50, required for ciliary assembly 




associated abnormalities. The cell-type specificity of this smoking-induced coping 
mechanism suggests that the bronchial epithelium’s capacity for detoxification 
may be compromised if ciliated cells are lost due to injury or disease. 
Several studies have reported that smoking is associated with increased 
mucous production and goblet cell hyperplasia in the bronchus9-14. Loss of club 
cells (SCGB1A1+) has been reported in smoker bronchioles9-10, but this is the 
first instance in which a similar observation has been made in the mainstem 
bronchus. We found that goblet cell hyperplasia (GCH) is a regional 
phenomenon interspersed amongst morphologically normal (MN) tissue areas. 
The determinants of GCH prevalence are unclear, but it has been shown that 
cytokine treatment (e.g. IL-13 and IL-4)55-57 and viral infection (e.g. Rhino virus 
and Poly(I:C))58-59 can increase MUC5AC expression and goblet cell abundance. 
The specific catalyst for GCH in response to smoke exposure is unknown, but 
genes highly expressed by goblet cells (e.g. BPIFB1, PIGR) suggest that 
immunological interplay may be a factor60-61. Characterization of bronchial white 
blood cell (WBC) infiltrates, epithelial-WBC interactions, and the airway 
microbiome might provide critical insight into this mechanism. Furthermore, there 
is evidence that both basal and club cells are capable of goblet cell 
differentiation51,62. However, the origins of newly formed goblet cells in the 
airways of smokers have not been explicitly described. Functional implications for 
goblet cell expansion and club cell loss are unclear, but a similar phenotype has 




fluidity, the formation of mucosal plugs, and impaired mucociliary clearance was 
observed63-64. Murine models have also shown that MUC5B loss is associated 
with impaired mucociliary clearance, airflow obstruction, and respiratory 
infection65.  
Smoking-induced goblet cell hyperplasia coincided with the appearance of 
a previously uncharacterized subpopulation of CEACAM5+ KRT8+ (MUC5AC-) 
cells. Established cell type marker gene expression was not detected in this 
subpopulation, therefore CEACAM5+ KRT8+ cells were referred to as 
indeterminate. Murine models have shown that basal cells give rise to a KRT8+ 
intermediate state, referred to as suprabasal, prior to ciliated or secretory 
specification62. Basal cells also take on a suprabasal phenotype when 
regenerating luminal cell types in murine injury models66. However, the 
suprabasal phenomenon has not been characterized in the human bronchus and 
little is known regarding intermediate epithelial subpopulations. Furthermore, the 
involvement of a KRT8+ intermediate state in club cell trans-differentiation has 
not been explored. Goblet cell differentiation required for the onset and 
maintenance of smoking-associated GCH might involve a pro-goblet precursor 
subpopulation, but the explicit role of CEACAM5+ KRT8+ cells in this context is 
unclear.  
Results indicated that in the airways of smokers, CEACAM5 is strongly co-
expressed with CEACAM6. The CEACAM5 and CEACAM6 proteins have 




migration across numerous tissue types, including the lung, colon, and 
pancreas67-70. CEACAM5 and CEACAM6 have the capacity to bind certain 
bacterial proteins, which has been shown to enhance epithelial adhesion to the 
extracellular matrix71. Alveolar type II cells also express CEACAM6 (in the 
absence of smoke exposure), which may have an anti-apoptotic function and 
play a role in surfactant stabilization72. Therefore, induced expression of 
CEACAM6 in the large airways suggests that smoking might cause bronchial 
epithelial cells to acquire characteristics of alveolar cells, but further investigation 
is required. 
In the airways of former smokers, it has been reported that CEACAM5 
expression is permanently up-regulated, whereas genes specifically expressed 
by goblet cells, such as MUC5AC, SPDEF, and AGR2, return to normal, never 
smoker levels post-smoking cessation31. These findings suggest that goblet cell 
expansion is temporarily induced by smoke exposure, whereas non-goblet 
CEACAM5+ cells might persist post-smoking cessation. The consequences of 
sustained CEACAM5 expression are unclear, but CEACAM5+ KRT5+ cells have 
been identified in bronchial premalignant lesions and lung squamous cell 
carcinoma (SCC)54, as well as numerous additional cancer types (e.g. gastric, 
pancreatic)73-74. Further investigation of this subpopulation of CEACAM5+ KRT8+ 
cells may provide insights into the cell-of-origin for lung SCC and the role of 
goblet cell hyperplasia in carcinogenesis. Overall, characterization of the 




will enhance our understanding of pathological abnormalities that arise during 






CHAPTER III – TRANSCRIPTOMIC ANALYSIS OF THE EFFECTS OF 
SMOKING ON BRONCHIAL EPITHELIAL DIFFERENTIATION 
Introduction 
The human bronchial epithelium is a heterogeneous, pseudostratified 
tissue composed of multipotent basal progenitor cells, responsible for tissue 
maintenance, in addition to ciliated and secretory cells, which perform 
mucociliary clearance1-2. The bronchial epithelium has been reported to be stable 
in vivo for several months without turnover under normal conditions75, but in 
response to injury from insults such as smoking, basal cells can replicate or 
replace damaged ciliated or goblet cells by differentiation3-5. However, in the 
context of long-term injury (such as that which might occur in the airways of 
smokers) the regenerative capacity of basal cells may be altered. Furthermore, 
when chronic bronchial epithelial abnormalities arise, the source of these 
abnormalities may be traced to permanent alterations to basal cells. 
It has been shown that in vitro basal cell differentiation at an air-liquid 
interface (ALI) produces a pseudostratified epithelial model that, from a 
transcriptomic perspective, closely resembles bronchial epithelial tissue procured 
from human donors76. Therefore, the ALI system can be used to analyze 
variations in the capacity for basal cells isolated from human donors to 
reconstitute a pseudostratified epithelium. In this study, we tested the hypothesis 
that long-term smoke exposure irreversibly alters basal cell differentiation. Basal 




The transcriptomes of ALI cultures were then profiled at various time points over 
the course of differentiation in order to identify biological processes affected by 
smoking history. We found that the onset of expression of genes involved with 
ciliogenesis was delayed during the differentiation of smoker cells. We also found 
that basal cells obtained from smokers expressed genes associated with the 
unfolded protein response (UPR). Findings from this study provide insight into 
the long-term effects of smoke exposure on bronchial epithelial differentiation. 
 
Methods 
Sample collection  
Bronchial airway tissue donated for scientific research was obtained from 
the National Disease Research Interchange (Philadelphia, PA) following an IRB-
approved protocol. Tissue was dissociated and basal cells were purified using 
established protocols. Basal cells were cultured and subjected to two passages 
prior to air-liquid interface differentiation77. 
Air-liquid interface (ALI) cultures. 
Bronchial epithelial cells were seeded onto type-I-collagen-coated tissue 
culture inserts (Millipore Corp., New Bedford, MA) and grown to confluence in 
submerged culture in bronchial epithelial growth medium (BEGM) (Lonza; CC-
3170). The cultures were then raised to the ALI by removing the culture medium 




(MatTek Corporation, Ashland, MA; 5.0 mg/ml insulin, 5 mg/ml transferrin, 0.5 nM 
hydrocortisone, 26 mg/ml bovine pituitary extract, 0.6 ng/ml EGF, 0.5 ng/ml 
epinephrine, 50 nM all-trans retinoic acid, 100u/ml penicillin, and 100mg/ml 
streptomycin). Cells were preserved in RNALater (ThermoFisher; AM7020) at 8 
time points (ALI culture days 0, 1, 3, 6, 9, 12, 16, 21) and stored at -80 °C until 
RNA isolation. Total RNA was isolated using the miRNeasy Mini kit (QIAgen; 
217004).  
RNA sequencing  
Libraries were sequenced on an Illumina HiSeq 2000, generating 100-
base paired-end reads.  Samples were multiplexed using Illumina TruSeq 
adapters to four samples per flowcell lane, and demultiplexing and FASTQ file 
generation were accomplished using CASAVA version 1.8.2, with the default 
settings, i.e., the last base of each raw read was trimmed off, and reads that 
failed Illumina's chastity filter [brightest intensity / (brightest intensity + second 
brightest intensity) < 0.6 for at least two of the first 25 cycles] were automatically 
removed. 
Data preprocessing  
Reads that passed chastity filtering were aligned to the human genome 
(build hg19) using TopHat2 (version 2.2.2), setting the estimated mean and 
standard deviation of the insert size to -25 and 50 bases, respectively.  A BED 




or the mitochondrial chromosome) was constructed from Ensembl build 74 by 
merging the unique exons from all Ensembl Transcripts within each ENSG record 
into a single locus. This BED file was used to determine the number of reads 
aligning to each Ensembl Gene locus with HTSeq (version 0.6.1). The 
SCAN.UPC R package (version 1.0.0) was used to determine whether a gene 
was expressed above background levels, allowing for the removal of genes that 
were not detected in at least two samples. 
Statistical analysis of RNA sequencing data 
Negative binomial generalized linear models were created using the 
MASS R package (version 7.3-23), modeling expression as a function of sex, 
sequencing depth (represented as millions of mapped reads), time, smoking 
status, and the interaction of time and smoking status. 
Gene set assignment  
Weighted Gene Coexpression Network Analysis (WGCNA)78 (version 
1.27-1) was used with default parameters and the following settings: power=9, 
TOMType="unsigned", minimum module size of 30, reassignThreshold=0, and 
mergeCutHeight=0.25.  Module 0 was then discarded, and Pearson correlations 
(r values) were computed between all pairs of genes within each remaining 
module.  Each module was then evaluated to determine whether it was 
associated with a bimodal distribution of r values (specifically, whether the 




negative r values was greater than an arbitrary value of 0.9).  Modules with a 
bimodal distribution of r values were broken into two anti-correlated gene sets by 
hierarchical clustering performed using Euclidean distance and RPM values that 
were z-normalized across all samples and trimmed to maximum and minimum z 
values of +2 and -2, respectively.  The directionality of each gene set was 
determined by inspecting the sign of the mean Spearman correlation coefficient 
computed between each gene in the gene set and experimental time point. 
MetaGene computation for RNA-seq data  
The expression of each gene set was summarized as a MetaGene as 
follows: First, the number of reads aligning to each gene was normalized to the 
total number reads in each sample to obtain a Reads Per Million (RPM) value, a 
pseudocount of 1 was added to each RPM value, and the result was log2-
transformed.  Then, the log2(RPM+1) values for each gene were z-normalized 
(to a mean of zero and standard deviation of 1) across all samples, and finally, 
the mean z-score was computed across all genes in the cluster for each sample. 
Functional annotation 
The DAVID web tool [http://david.ncifcrf.gov] was used to identify 
pathways and Gene Ontology (GO) terms that were significantly overrepresented 
within each cluster. Only clusters with significant GO term associations are 




Microarray data processing  
Raw CEL files obtained from the Gene Expression Omnibus (GEO) for 
Series GSE526479, GSE8213780, and GSE789531 were normalized to produce 
gene-level expression values using the implementation of the Robust Multiarray 
Average (RMA) in the affy R package (version 1.36.1) and an Entrez Gene-
specific probeset mapping (17.0.0) from the Molecular and Behavioral 
Neuroscience Institute (Brainarray) at the University of Michigan 
(http://brainarray.mbni.med.umich.edu). 
MetaGene computation for microarray data 
The expression of each gene set was summarized as a MetaGene as 
follows: RMA-transformed values values for each gene were z-normalized (to a 
mean of zero and standard deviation of 1) across all samples and the mean z-
score was computed across all genes in the cluster for each sample. 
Statistical analysis of computed MetaGenes 
For MetaGenes generated from RNA-Seq data, linear mixed effects 
models were created using the nlme R package (v3.1-128), modeling MetaGene 
expression (for RNA-Seq and microarray data) as a function of sex, smoking 
status, the interaction of time and smoking status, and donor treated as a random 
effect. For MetaGenes generated from microarray data obtained from GEO 






Identification of gene sets with time-associated expression patterns 
Basal bronchial epithelial cells acquired from a cohort of three healthy 
never smokers and three healthy current smokers (Table 4) were differentiated 
at an air-liquid interface (ALI). Cells from all donors were collected 1, 3, 6, 9, 12, 
16, and 21 days after the induction of ALI differentiation. Cells were also 
collected immediately prior to ALI induction (referred to as “day 0”) and were 
considered to be a pure population of basal cells. All samples were then 
transcriptomically profiled by RNA sequencing. Lowly expressed genes were 
removed from the dataset (leaving a set of 16,898 genes) and genes whose 
expression changed significantly with differentiation time were identified (FDR q < 
0.05, n = 15,908 genes). Weighted gene coexpression network analysis 
(WGCNA)78 was performed using all time-associated genes to identify 27 sets of 
co-expressed genes.  Gene sets were then separated into groups that were 






Table 4. Bronchial basal cells were isolated from 3 never smokers and 3 
current smokers. 
Basal cells were isolated from normal bronchial tissue obtained post-mortem 
from the National Disease Research Interchange (Philadelphia, PA) from never 






Expression of distinct sets of genes increased with bronchial epithelial 
differentiation  
The largest gene set (GS) that was positively correlated with time (GS-1A, 
n=4,906 genes; Figure 3.1) contained numerous genes with roles pertaining to 
known aspects of ciliary genesis and function, including an established 
transcriptional regulator of bronchial epithelial ciliogenesis, FOXJ1. Genes 
involved with intraflagellar transport (e.g., IFT88, IFT57, DYNC2H1, DYNC2L1), 
components of the ciliary axoneme (e.g., DNAH7, DNAH11), and filamentous 
polymers that line ciliary walls (e.g., TEKT2, TEKT4) were also detected in GS-
1A. MUC5AC, which is secreted by bronchial goblet cells, is also present, 
suggesting that this cluster may include elements of transcriptional programs 
specific to multiple cell types. 
The second largest gene set positively correlated with time (GS-1B, 
n=1,752 genes; Figure 3.1) contains numerous transcription factors with zinc 
finger motifs and genes required for various mechanisms of chromatin 
organization (e.g., KAT4, KDM5A). This cluster also contains genes involved with 
retinoic acid signaling (e.g., retinoic acid receptors RARB and RXRA), which is a 
known driver of secretory cell development81. Interestingly, SCGB1A1, which is 
expressed by club cells, was also assigned to this cluster. 
GS-1C (Figure 3.1) contained numerous genes encoding proteins that 
localize to the mitochondria, primarily those involved with oxidative 




dehydrogenases (e.g., NDUFA1, NDUFB1), and cytochrome C oxidase subunits 
(e.g., COX5B, COX7B). GS-1D was composed of genes whose protein products 
localize to the nucleus, such as major cell cycle transcriptional regulators (e.g., 
TP53, E4F1) as well as mediators of chromatin structure (e.g., SWI/SNF family 
members SMARCA4 and ARID1A) and organization (e.g., HDAC7, EHMT1). 
Annotated members of GS-1H include histone genes (e.g., HIST1H1B, 
HIST1H1C).  This gene set also contained several genes that have recently been 
established as early transcriptional regulators of ciliogenesis (e.g., MCIDAS, 
MYB, and CCNO)82-84 as well as a number of centrosomal protein (CEP) genes. 
Remaining clusters with significantly associated GO terms are less well 
defined. GS-1I (Figure 3.1) contains several well-established markers of airway 
secretory cells, including MUC5B, TFF3, and members of the PLUNC family 
(BPIFA1, BPIFA2, BPIFB1).  The transcriptional regulator, CEBPB, which is 
present in GS-1J (Figure 3.1), has been shown to be required for normal club 
cell differentiation in murine airways85. Additionally, genes that encode 
components of the squamous epithelial cornified envelope (e.g., CNFN, CRNN, 






Figure 3.1 - WGCNA was used to identify sets of genes whose expression 
increased during bronchial epithelial differentiation. 
WGCNA was used to detect co-expressed gene sets amongst the 15,908 genes 
whose expression was significantly associated with differentiation time (FDR q < 
0.05). Of the 27 gene sets identified, 15 were positively correlated with time and 
gene expression was visualized by heatmap (z-normalized reads per million 
(RPM) values). Gene sets were ordered from largest to smallest (GS-1A-O). The 
day 0 sample from current smoker 2 is missing (white column). A MetaGene was 
generated for each gene set for each donor over time. Mean MetaGene 
expression values across all donors were displayed to the right of each gene set 





Expression of distinct sets of genes decreased with bronchial epithelial 
differentiation 
The largest gene set that was negatively correlated with time was GS-2A, 
which (GS-2A, n=1,565 genes; Figure 3.2) contained genes related to mitosis, 
such as those involved with cell cycle checkpoints (e.g., CDK1, CDK4, CCNB1, 
CCND1), DNA replication (e.g., POLA1, MCM2, ORC1), chromatin condensation 
(e.g., NCAPH, NCAPD3), centromeres (e.g., CENPA, KNTC1), and chromosome 
segregation during anaphase (e.g., KIF2C, ESPL1). 
The second largest gene set (GS-2B, n=1,334 genes; Figure 3.2) that 
was negatively correlated with time was predominantly comprised of genes 
involved with protein synthesis, such as components of the ribosomal 40S (e.g., 
RPS23) and 60S (e.g., RPL18) subunits and translation elongation factors (e.g., 
EEF2, EEF1D). Additionally, a subset of genes in this cluster encodes enzymes 
present in the pentose phosphate pathway (e.g., G6PD, PGD, TALDO1). 
GS-2C (n = 1,222 genes; Figure 3.2) was comprised of genes required for 
processes critical to endoplasmic reticulum (ER) function, such as chaperones 
(e.g., HSP90B1, HSPA13), regulators of ER luminal retention (e.g., KDELR1, 
KDELR2), and coat proteins implicated in ER-Golgi trafficking (e.g., SEC22C, 
SEC24D). Interestingly, genes explicitly affiliated with the unfolded protein 
response (UPR) (e.g., ERN1, HERPUD1), which is a stress mechanism induced 





Genes present in GS-2D (n = 833 genes; Figure 3.2) were involved with a 
variety of molecular processes, such as ribosome biogenesis (e.g., NOP10, 
UTP14A), pre-mRNA splicing (e.g., PRPF4, PRPF40A), and production of small 
28S (e.g., MRPS16, MRPS28) and large 39S (e.g., MRPL9, MRPL36) 
mitochondrial ribosomal subunits. 
GS-2E (n = 462 genes; Figure 3.2) contained genes encoding proteins 
that localize to the nucleus, such as RNA polymerase subunits (e.g., POLR1A, 
POLR2D) and pre-mRNA splicing factors (e.g., SF1, SRSFS9). GS-2F (n = 378 
genes; Figure 3.2) was composed of genes with functions similar to those of GS-
2B, such as translation elongation factors (e.g., EEF1A1, EEF1B2) and 
components of ribosomal subunits (e.g., RPL11, RPS14). 
Amongst the members of GS-2G (n = 319 genes; Figure 3.2) were the 
cytokeratin basal cell marker genes, KRT5 and KRT14. This gene set also 
contained several genes required for the formation of gap junctions (e.g., GJA1, 
GJB2) and desmosomes (e.g., DSC2, DSC3). Several secreted extracellular 
matrix proteins, such as those in collagen (e.g., COL4A6, COL7A1) and laminin 
(e.g., LAMA3, LAMC1) families, as well as basal cell marker TP63, were present 
in GS-2H (n = 218; Figure 3.2). GS-2J (n = 62 genes) contained select hypoxia-
response genes (e.g., BNIP3, PGF). Additional poorly annotated gene sets 





Figure 3.2 - WGCNA was used to identify sets of genes whose expression 
decreased during bronchial epithelial differentiation. 
WGCNA was used to detect co-expressed gene sets amongst the 15,908 genes 
whose expression was significantly associated with differentiation time (FDR q < 
0.05). Of the 27 gene sets identified, 12 were negatively correlated with time and 
gene expression was visualized by heatmap (z-normalized reads per million 
(RPM) values). Gene sets were ordered from largest to smallest (GS-2A-L). The 
day 0 sample from current smoker 2 is missing (white column). A MetaGene was 
generated for each gene set for each donor over time. Mean MetaGene 
expression values across all donors were displayed to the right of each gene set 





Overlap was observed with published microarray data profiling bronchial 
epithelial differentiation 
To confirm that our findings were concordant with those previously 
reported, we compared our results with those of Ross et al.79, who performed 
transcriptomic microarray profiling of bronchial epithelial cells obtained from 
healthy never smokers and differentiated at an ALI, followed by k-means 
clustering to identify five gene sets (n=2,837 Affymetrix probesets) whose 
expression was differentially expressed with respect to time.  Fisher’s exact test 
(FET) was performed to determine the degree of overlap of each of our 27 
WGCNA-identified gene sets with the 5 published gene sets from Ross et al. 
(Figure 3.3).  The five Ross gene sets displayed varying degrees of overlap with 
the WGCNA gene sets, but two relationships were especially predominant: Ross 
gene sets 2 and 5 intersected specifically with GS-1A (ciliary genes) and GS-2A 
(mitotic genes), respectively.  Ross GS-1 was more diffuse, but predominantly 
overlapped with GS-1I, which was marked by secretory genes; similarly, Ross 
GS-3 overlapped with many WGCNA gene sets, but its strongest intersection 
was with GS-2H (extracellular matrix genes).  Finally, Ross GS-4 overlapped 
strongly with several WGCNA gene sets, including GS-2J (hypoxia-response), 






Figure 3.3 - Differentiation-associated gene sets identified by RNA-Seq 
partially overlapped with those identified in published microarray data. 
Fisher’s exact test (FET) was used to determine overlap amongst the 27 gene 
sets identified by WGCNA (GS-1A-O, GS-2A-L) and the 5 gene sets identified by 
Ross et al. Degree of cluster overlap was depicted by heatmap visualization of 
FET p-values, ranging from no overlap (p > 0.05 = white) to highly significant 





Identification of gene sets associated with the interaction of time and 
smoking status 
We then identified genes whose expression was significantly associated 
with the interaction of time and smoking status (i.e., genes whose pattern of 
expression with respect to time is dependent on smoking status) (n = 2,258 
genes; FDR q < 0.05). The enrichment of genes associated with the time:status 
interaction term within each of the 27 time-associated gene sets was then 
assessed and six were significant (FET FDR q < 0.05) for this relationship (GS-
1A, -1C, -1L, -1M, -2D and -2J). Metagenes were computed for all never and 
current smokers at each time point using the time:status-associated genes 
detected in each of the six gene sets. Metagene expression was significantly 
associated with the interaction of time and smoking status (time:status p < 0.05) 
in each case and we chose to examine the two largest gene sets (GS-1A and 
GS-2C) in greater detail. 
Delayed onset of ciliogenesis was observed in smoker cells 
As previously mentioned, gene set GS-1A was significantly enriched in 
genes involved with ciliary assembly and organelle biogenesis.  However, the 
cilium is a complex organelle involving several hundred proteins, many of which 
have not been explicitly annotated.  For this reason, we used a curated set of 
genes with substantial evidence for involvement with ciliogenesis86 as a "gold 
standard" (n = 371 genes) and found significant overrepresentation (FET p = 1.2 




time:status-associated members of GS-1A (Figure 3.4A) showed that the up-
regulation of genes involved with ciliogenesis was delayed during the 
differentiation of cells derived from smokers as compared to never smokers 
(time:status p = 2.3 x 10-4). Established transcriptional regulator of ciliogenesis, 
FOXJ1, was also included amongst time:status-associated GS-1A genes and its 
expression was similarly delayed during smoker cell differentiation. 
Interestingly, GS-1H possessed a kinetic signature that was similar to that 
of GS-1A from days 0-12, but dropped sharply before day 21.  The onset and 
amplitude of the expression of these genes was also delayed in smoker cells.  As 
discussed earlier, this cluster contained several essential regulators of the 
ciliogenic transcriptional program upstream of FOXJ1, including MCIDAS82, 
MYB83, and CCNO84 (Figure 3.1).  Furthermore, this cluster was also enriched in 
components of the centrosome, the core component of the ciliary basal body, 
whose apical docking is a necessary precursor to the extension of the axoneme, 
suggesting that the delay in ciliogenesis might also be related to this gene set. 
To assess the direct effects of smoke exposure on the expression of 
ciliogenesis genes in vitro, we examined a publicly available microarray dataset 
in which fully differentiated human bronchial epithelial air-liquid interface cultures 
(day 21) were exposed to cigarette smoke. We found that expression of the 
time:status-associated genes from GS-1A was significantly down-regulated (t-
test p = 3.0 x 10-3) in smoke-exposed cultures, relative to controls (Figure 3.4B). 




genes in vivo, we examined a publicly available dataset in which bronchial tissue 
from never, former, and current smokers collected by bronchoscopic brushing 
was profiled by microarray. We found that the expression of the time:status-
associated genes from GS-1A was significantly down-regulated in both former (t-
test p = 0.03) and current (t-test p = 0.01) smokers, relative to never smokers 
(Figure 3.4C). These results suggested ciliogenesis may be reduced by smoke 
exposure both in vitro and in vivo. Furthermore, diminished expression of this 
gene set in former smokers indicated that despite smoking cessation, the 





Figure 3.4 - Delayed onset of ciliogenesis was observed during 
differentiation of current smoker cells. 
(A) A MetaGene was generated from gene set GS-1A for each donor over time 
and mean expression across never smoker and current smoker cells was plotted. 
(B) GS-1A MetaGene expression was examined in published microarray data 
generated from fully differentiated (day 21) bronchial epithelial ALI cultures 
exposed to cigarette smoke (SMK) or air as a control. The Student’s t-test was 
used to assess differential expression associated with smoke exposure (p = 3.0 x 
10-3). (C) GS-1A MetaGene expression was examined in published microarray 
data generated from bulk bronchial brushings procured from never, former, and 
current smokers. The Student’s t-test was used to assess differential expression 





The unfolded protein response was detected in smoker basal cells 
The expression of gene set GS-2C was largely restricted to day 0 (prior to 
differentiation) and was strongly up-regulated in samples from smokers (Figure 
3.5A). MetaGene scores computed from all time:status-associated members of 
GS-2C (Figure 3.5A) were significantly associated with the interaction of time 
and smoking status (time:status p = 3.8 x 10-10). Functional annotation of the 
genes in GS-2C indicated that they were associated with the unfolded protein 
response (UPR), but as many of the genes in this gene set have not yet been 
functionally characterized. Therefore, this association was examined in greater 
detail by using a set of 2562 genes whose expression was up-regulated in 
response to an established UPR-inducing agent, tunicamycin, in vitro87. Results 
indicated that this set of genes is significantly overrepresented (FET p = 4.0 x 10-
26) within GS-2C. Furthermore, this gene set included several well-known 
transcriptional regulators of the UPR (e.g. ATF3, ATF4, CHOP). 
We again examined microarray data generated from fully differentiated 
human bronchial epithelial air-liquid interface cultures (day 21) exposed to 
cigarette smoke to assess the effects of direct smoke exposure on the 
expression of UPR genes. We found that expression of the time:status-
associated genes from GS-2C was significantly up-regulated (t-test p = 8.1 x 10-
4) in smoke-exposed cultures, relative to controls (Figure 3.5B). Furthermore, 
UPR gene expression was analyzed in microarray data generated from 




found that the expression of the time:status-associated genes from GS-2C was 
significantly up-regulated (t-test p = 0.02) in current smokers, relative to never 
smokers (Figure 3.5C). However, expression was not altered in former smokers. 
These results indicated that the UPR is induced by smoke exposure both in vitro 
and in vivo. Similar expression levels of UPR genes in never and former smokers 
suggested that the UPR may not be permanently activated by smoking, but basal 





Figure 3.5 - The unfolded protein response was detected in current smoker 
basal cells. 
(A) A MetaGene was generated from gene set GS-2C for each donor over time 
and mean expression across never smoker and current smoker cells was plotted. 
(B) GS-1A MetaGene expression was examined in published microarray data 
generated from fully differentiated (day 21) bronchial epithelial ALI cultures 
exposed to cigarette smoke (SMK) or air as a control. The Student’s t-test was 
used to assess differential expression associated with smoke exposure (p = 8.1 x 
10-4). (C) GS-1A MetaGene expression was examined in published microarray 
data generated from bulk bronchial brushings procured from never, former, and 
current smokers. The Student’s t-test was used to assess differential expression 






In this study, we used RNA sequencing to identify sets of co-expressed 
genes with various patterns of time-dependent expression during in vitro air-liquid 
interface (ALI) differentiation of basal cells isolated from never and current 
smokers. Ross et al. previously performed a transcriptomic analysis of ALI 
differentiation, but it was restricted to never smoker cells and data was generated 
by microarray79. Our RNA sequencing analysis examined ALI differentiation in 
greater depth due to the use of a more complete genome annotation. 
Furthermore, the use of WGCNA to identify sets of co-expressed genes provided 
a more comprehensive analysis than the k-means clustering approach employed 
by Ross et al. Functional annotation of the identified gene sets therefore serves 
as a valuable catalogue of biological processes associated with human bronchial 
epithelial differentiation.  
The bronchial epithelial transcriptome is comprised of sets of co-
expressed genes associated with well-annotated molecular processes, many of 
which have highly variable expression patterns. For example, expression of gene 
set GS-1A, which was comprised of ciliogenesis genes, gradually increased from 
day 3 to day 16, whereas GS-1C, which contained oxidative phosphorylation 
genes, peaked at day 3 and remained highly expressed throughout 
differentiation. By contrast, GS-2A, comprised of genes involved with cell 
division, was gradually reduced from day 0 to day 16 and GS-2H, which 




expected that basal cell-specific gene expression would decrease over time, 
whereas ciliated cell-specific gene expression would increase over time. 
However, the relationship between oxidative phosphorylation and ciliated cell 
differentiation, for example, has not been explored. 
We also identified gene sets that were abnormally expressed during the 
differentiation of ALI cultures grown from cells isolated from current smokers. 
Specifically, we observed that the onset of expression of genes involved with 
ciliary structure, function, and biogenesis was delayed in smoker cultures. 
Furthermore, we observed that this gene set was down-regulated in bronchial 
tissue profiled directly from current and former smokers. Prior in vitro studies 
have also shown that exposure to cigarette smoke extract during ALI 
differentiation reduces ciliated cell numbers88. Altogether, data suggests that 
smoking interferes with the expression of cilia-specific genes and might have 
long-term consequences on the process of ciliogenesis. Expression of 
transcriptional regulators of ciliogenesis, such as FOXJ1, MCIDAS, and MYB, 
was also delayed in smoker cells, which suggests that an unknown upstream 
regulator may be contributing to this phenotype.  
Histological analyses of ciliated cells isolated from current smokers have 
shown that ciliary length is reduced compared to that of never smoker cells7. If 
smoke exposure damages cilia and repair or replacement is necessary, 
mechanisms prohibiting or delaying ciliogenesis might contribute to diminished 




projection through airway mucosa and impair mucociliary clearance7-8. 
Furthermore, impaired mucociliary clearance has been linked to increased 
susceptibility to respiratory infection89. In theory, impaired ciliogenesis, reduced 
ciliary length, and mucociliary clearance defects might lead to an abnormal 
accumulation of inhaled microorganisms and increased incidence of infection. 
Our results also led to the identification of smoking-associated alterations 
to basal cell gene expression characterized by the up-regulation of genes 
involved with the unfolded protein response (UPR). This finding indicates that the 
UPR persists in smoker basal cells that have been removed from their hosts and 
have undergone several passages in vitro. Previous studies have shown that 
smoke exposure induces the UPR in vitro90 and in vivo91-92. However, this is the 
first instance in which smoking-induced UPR has been specifically localized to 
basal cells, although a larger cohort of donor cells should be evaluated to confirm 
this finding. 
Oxidants and free radicals are prevalent within cigarette smoke37 and 
exposure results in extensive oxidative protein damage38. Oxidant-induced 
protein modification has been shown to cause proteins to aggregate and 
accumulate in the endoplasmic reticulum, leading to the induction of stress 
mechanisms that drive the UPR93. The UPR in turn promotes the expression of 
pro-survival and anti-oxidant genes and activates pathways that inhibit protein 
synthesis, regulate protein transport, and promote mRNA and protein 




associated diseases, such as lung cancer94, chronic obstructive pulmonary 
disease (COPD)33, and idiopathic pulmonary fibrosis95. However, it is unclear if 
disease-associated UPR is directly linked to smoking or driven by independent 
processes. 
We found that the expression of UPR-associated genes in smoker cells 
returned to normal, never smoker levels upon induction of ALI differentiation. 
However, previous studies have demonstrated that the UPR and ciliogenesis 
might be linked8. Specifically, it was shown that exposure of murine tracheal 
epithelial ALI cultures to smoke reduced both ciliary length and overall ciliated 
cell numbers and caused defects in mucociliary clearance8. However, if cultures 
were treated with a chemical chaperone (4-phenyl butyric acid) that alleviates 
protein aggregation driving the UPR, the smoking-associated mucociliary 
clearance defects were prevented8. Therefore, although our data suggests that 
the UPR does not persist throughout the course of bronchial epithelial 
differentiation, further investigation into the relationship between the UPR and 
ciliogenesis may be warranted. 
Our data suggests that smoke exposure has long-term effects on 
bronchial epithelial differentiation. We identified numerous, unique expression 
patterns that contribute to biological processes that are activated or de-activated 
as cells transition from a pure population of basal progenitor cells to a complex, 
pseudo-stratified epithelium. We found that several of these processes may be 




of genes involved with ciliogenesis was delayed during smoker cell 
differentiation. Furthermore, we found that smoker basal cells specifically 
express genes associated with the UPR. The functional consequences of 
delayed ciliogenesis and basal cell-specific UPR activation are unclear, but these 
findings might contribute to permanent abnormalities observed in the bronchial 






CHAPTER IV – CONCLUSIONS AND FUTURE DIRECTIONS 
Conclusions 
In these studies, we have shown that smoking-associated bronchial gene 
expression alterations can be traced to specific cell types. We found that smoker 
ciliated cells are involved with the detoxification of smoke-derived chemicals, like 
aldehydes and ketones. We also identified a smoking-associated shift in the 
presence of known cell types. Specifically, club cell depletion, goblet cell 
expansion, and regional goblet cell hyperplasia was observed in smokers. 
Furthermore, a previously uncharacterized CEACAM5+ KRT8+ epithelial 
subpopulation was identified in smokers. In addition to these findings, it was 
observed that certain smoking-associated abnormalities may be long-lasting, 
potentially as a consequence of permanent alterations to basal cells. Specifically, 
it was found that basal cells procured from smokers that were expanded for 
several passages in vitro maintain a distinct gene expression profile 
characterized by the unfolded protein response (UPR). Furthermore, during 
differentiation, it was observed that the expression of genes involved with 
ciliogenesis was delayed in cells isolated from smokers. 
 
Long-term consequences of smoking 
Prior studies have shown that a subset of smoking-associated bronchial 
gene expression alterations may be permanent. Evidence uncovered in these 




affect their capacity for differentiation. Additional data revealed that previously 
identified long- and short-term gene expression alterations predominantly localize 
to non-basal epithelial cell types. The detoxification program activated in smoker 
ciliated cells is largely composed of genes that are up-regulated in current 
smokers, but reversible upon smoking cessation. Therefore, this ciliated cell 
metabolic program likely serves as an acute response to smoke exposure. 
Genes specifically expressed by goblet cells are also exclusively up-regulated in 
current smokers (Figure 4.1A,D), which indicates that goblet cell expansion, 
including goblet cell hyperplasia, is likely reversible. The club cell transcriptional 
program, however, appears to have a multi-faceted response to smoke. For 
example, previous reports have shown that MUC5B is irreversibly down-
regulated by smoking, whereas SCGB1A1 is reversible. This suggests that club 
cells, which were described in these studies as SCGB1A1+ MUC5B+, may 
repopulate the airways post-smoking cessation, but elements of their 
transcriptional program may be lost. In conjunction with studies that have 
illustrated the association between MUC5B loss and defects in mucociliary 
clearance, findings suggest that smoking-induced club cell alterations may 
permanently alter bronchial epithelial function. Furthermore, smoking-induced 
genes co-expressed by goblet cells and the newly identified CEACAM5+ KRT8+ 
subpopulation (GS-15) were persistently up-regulated in the airways of former 
smokers (Figure 4.1A,C). Given that smoking-induced goblet-specific genes are 




a persistent presence of CEACAM5+ KRT8+ cells post-smoking cessation. This 
concept is reinforced by analyses indicating that genes specifically expressed by 
CEACAM5+ KRT8+ cells (e.g. GS-12) are also up-regulated in both former and 
current smokers (Figure 4.1A,B). Future studies should be undertaken to 
analyze the bronchial epithelium of former smokers, but current findings suggest 
that CEACAM5+ KRT8+ cell expansion and loss of MUC5B expression might 





Figure 4.1 - Gene sets detected in CEACAM5+ KRT8+ cells were persistently 
up-regulated in former smoker bronchial brushings. 
(A) Expression of gene sets GS-1, GS-12, and GS-15 in clusters C-3 and C-9 
was visualized by heatmap (z-normalized TPM values). (B) GS-1, (C) GS-12, 
and (D) GS-15 MetaGene expression was examined in published microarray 
data generated from bulk bronchial brushings procured from never, former, and 
current smokers. The WRS test was used to assess differential expression 
associated with former smoker (GS-1 p = 0.09; GS-12 p = 0.03; GS-15 p = 0.02) 






Overlap between smoking- and lung cancer-associated phenotypes 
Lung squamous cell carcinoma is characterized by extensive KRT5+ basal 
content, but one study reported that a subset of KRT5+ cells in both pre-
malignant lesions and tumors also expresses CEACAM5. Single cell RNA-Seq 
data reported in this thesis does not indicate that KRT5+ cells in the airways of 
healthy smokers express CEACAM5. However, immunostaining for KRT5 and 
CEACAM5 revealed that a rare subpopulation of KRT5+ CEACAM5+ cells is 
detectable in smoker bronchial tissue (Figure 4.2) in the absence of pre-
malignant phenotypes, such as basal cell hyperplasia. This finding suggests that 
while smoking-associated CEACAM5+ KRT5+ cells in normal airways are rare, 
their emergence might represent a critical change that precedes pre-malignancy. 
Drivers of CEACAM5 expression, specifically by KRT5+ cells, are unclear, but if 
findings can be reproduced in a model system or isolated directly from human 
tissue, future studies should be undertaken in which this subpopulation is 
exhaustively functionally interrogated. There may be a normal lineage 
relationship amongst CEACAM5+ KRT5+ cells, CEACAM5+ KRT8+ cells, and 
CEACAM5+ goblet cells. However, characterizing the process by which cells 
remain in a CEACAM5+ KRT5+ state or expand to form pre-malignant lesions 





Figure 4.2 - A rare subpopulation of CEACAM5+ KRT5+ cells was observed 
in smoker bronchial tissue. 
Bronchial tissue procured at UMCG from never and current smoker donors was 
immunostained for CEACAM5 and KRT5. A representative image from current 
smoker tissue was displayed and arrows were used to specify examples of 





Lung cancer biomarker may be derived from specific cell types 
The single cell RNA-Seq data described in this thesis is a proof of concept 
for future single cell resolution analyses of additional airway gene expression 
biomarkers. Past work describing a lung cancer-associated signature in 
histologically normal bronchial tissue has led to the development of a gene 
expression-based diagnostic test. Although this signature was generated from 
non-cancerous tissue, functional aberrations specific to certain cell types or shifts 
in tissue composition might provide important insights into changes that facilitate 
tumorigenesis and malignancy. Furthermore, understanding the cell type-specific 
contributions to this signature might lead to diagnostic improvements. When 
profiling bulk bronchial tissue, the RNA content of irrelevant cell types could 
mask the transcriptional phenotype of interest and hinder diagnostic efficacy. If a 
test was designed that directly probed the activity of specific cell types, while 
bypassing sources of experimental noise, one could plausibly enhance 
diagnostic sensitivity and specificity. Therefore, preliminary data was generated 
from bronchial cells procured from six former smokers, three of whom were 
diagnosed with lung adenocarcinoma (Figure 4.3A). Initial results indicate that 
genes previously identified as up-regulated in the airways of cancer patients 
localized to epithelial subpopulations, whereas those down-regulated in cancer 
patients were detected in white blood cell types (not shown). Furthermore, we 
observed an overall increase in the epithelial to white blood cell ratio amongst 




that cancer-associated gene expression alterations are driven by either an 
increase in epithelial content or a reduction in white blood cell infiltration. 
However, samples must be profiled from additional patients, including smokers 
with and without adenocarcinoma, as well as other cancer types (e.g. squamous 
cell carcinoma, etc), in order to establish robust findings that can be leveraged 





Figure 4.3 - White blood cell depletion and increased epithelial content was 
observed in bronchial brushings procured from former smokers with lung 
adenocarcinoma. 
Single-cell RNA-Seq data was generated from cells isolated from bronchial 
brushings procured from 3 former smokers with lung adenocarcinoma (LC) and 3 
former smokers without cancer (NC) (n = 190 cells per donor) and LDA was used 
to identify distinct cell clusters and gene sets. (A) t-SNE was used to visualize 
donor cancer status as well as (B) clusters of neutrophils (FET p 1.0 x 10-3), 
macrophages (FET p 1.2 x 10-4), and B cells (FET p 1.4 x 10-8), which were 




of basal (FET p 1.2 x 10-18), secretory (FET p 1.2 x 10-6), and ciliated cells (FET p 
4.8 x 10-5), which were enriched (FET p < 0.05) with cells from donors with 
cancer (LC). (C) Expression of gene sets specific to the aforementioned clusters 
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